Delivery Order SPE2DB25D3012-SPE2DB25FWZCF
- Not listed
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $11,239.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. The contract, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency (DLA) awarded a $31,833.56 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $9,973.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical product, with an ultimate completion date of July 30, 2025. This is a non-set-aside award issued on July 29, 2025, with fulfillment based at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $6,641.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Taltz 80 mg/ml autoinjectors with a ceiling value of $4,197.10. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, reflecting a short fulfillment timeline for this pharmaceutical product. The contract utilizes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.24 on August 20, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with a completion date of August 21, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency awarded a delivery order valued at $28,410.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, with an ultimate completion date of August 21, 2025, was awarded on August 20, 2025, with no set-aside designation. The contract represents a competitive award under AmerisourceBergen's larger federal contracting relationship with DLA and reflects...
- The Defense Logistics Agency awarded a $24,342.24 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) units, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZCFDelivery Order
The Defense Logistics Agency awarded a $19,479.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is unclassified as a set-aside and represents a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency and broader military healthcare systems by providing TALTZ, a specialty pharmaceutical product used in treating various conditions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio with DLA centered on delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The competitively awarded contract reflects the company's established capability to fulfill federal procurement requirements through its comprehensive pharmaceutical supply network supporting military personnel and veterans worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 8/8/25 |